Remote administration of hyaluronic acid to mammals

Details Remote administration of hyaluronic acid to mammals Remote administration of hyaluronic acid to mammals

C - Chemistry, Metallurgy

08

B

167/199

C08B 37/08 (2006.01) A61K 9/00 (2006.01) A61K 9/08 (2006.01) A61K 31/715 (2006.01)

Patent

CA 1314218

Mo-2817 REMOTE ADMINISTRATION OF HYALURONIC ACID TO MAMMALS ABSTRACT OF THE DISCLOSURE The present disclosure is concerned with the discovery that hyaluronic acid, an agent well known to reduce the sequelae of trauma in mammalian joint tissue when applied directly to the traumatized tissue, will be carried to such traumatized tissue by the mammal's natural processes if applied at a site remote from the traumatized tissue. Thus, hyaluronic acid, in any therapeutically acceptable form, can be administered by the typical remote routes including intravenous, intramuscular, subcutaneous and topical. This makes the utilization of hyaluronic acid much more convenient and attractive. For instance the treatment of arthritis in horse or human joints with hyaluronic acid no longer requires more difficult intra articular injections. Mo-2817

533391

Affiliated with

Also associated with

Rating

Remote administration of hyaluronic acid to mammals does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Remote administration of hyaluronic acid to mammals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Remote administration of hyaluronic acid to mammals will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1173827